Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 701 (USA) (Dr. Reyes)
· consented 2012-08-05
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild ATRIOVENTRICULAR BLOCK SECOND DEGREE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-08-26 (study day 22.0); relationship: POSSIBLE
mild
assessed
2026-08-18
Mild ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-08-07 (study day 3.0); relationship: POSSIBLE
moderate
assessed
2026-08-18
Moderate ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-08-07 (study day 3.0); relationship: PROBABLE
mild
assessed
2026-08-18
Mild ERYTHEMA — outcome: RECOVERED/RESOLVED; onset 2012-08-07 (study day 3.0); relationship: POSSIBLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.